Cardinal Health Recalls Dexamethasone Sodium Phosphate Eye Drops
Cardinal Health Inc. is recalling 318 droptainers of Dexamethasone Sodium Phosphate 0.1% eye drops due to temperature excursions during storage.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text explicitly states no illnesses or injuries have been reported, and the hazard is a theoretical risk from storage conditions rather than a confirmed high-risk pathogen or structural defect.
Plain-English summary
Cardinal Health Inc. is recalling 318 droptainers of Dexamethasone Sodium Phosphate 0.1% 5ML eye drops. The recall is identified by recall number D-0447-2021 and involves product with code 353351. The affected units were distributed in Florida, Georgia, and South Carolina.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations, specifically intermittent exposure to temperature excursions during storage. The source text does not report any illnesses, injuries, or deaths associated with this recall.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for further instructions. The source text does not specify a return address or refund process.
The recalled product
- Product
- DEXAMETH SOD PHOS 0.1% 5ML; NDC/UPC 24208072002; RX; DROPS
- Manufacturer
- Cardinal Health Inc.
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 318
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 353351
Distribution
Part of a larger recall action
This product is one of 198 recalled by Cardinal Health Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 198 products in this recall →Related recalls
Same manufacturer · Cardinal Health Inc.
See all →- HighEnoxaparin syringe bags recalled after being labeled with the wrong strength
FDA (Drugs) · 2025-09-03
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateWegovy injection recalled due to temperature exposure during shipping
FDA (Drugs) · 2025-05-07
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
Similar recalls
- SevereNatures Pharmacy Recalls Dexamethasone Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2014-03-12
- CriticalFDA Recalls Non-Sterile Dry Eye Relief Drops Due to Bacterial Contamination
FDA (Drugs) · 2023-11-29
- HighDexamethasone Eye Drops Recalled Due to Insanitary Compounding Conditions
FDA (Drugs) · 2019-04-17
- HighHealth Innovations Pharmacy Recalls Phospholine Iodide Eye Drops
FDA (Drugs) · 2015-05-20
- SevereCyclosporine 1% Ophthalmic Drops Recalled for Sterility Concerns
FDA (Drugs) · 2013-07-10
- SevereFDA Recalls LEADER Brand Lubricant Eye Drops Due to Non-Sterility Risk
FDA (Drugs) · 2023-11-29